Monitor the November 19 annual meeting for voting outcomes, particularly director elections and say-on-pay results, which may signal shareholder sentiment. No immediate trading catalyst from this routine notice.
Price Chart
Executive Summary
Oncolytics Biotech filed additional definitive proxy soliciting materials (DEFA14A) in connection with its upcoming Annual Meeting of Stockholders scheduled for November 19, 2026. The filing is a routine notice regarding internet availability of proxy materials and does not contain new substantive proposals or financial data.
Key Financial Metrics
Key Facts
- Annual Meeting to be held virtually on November 19, 2026 at 4:00 p.m. ET
- Stockholders will vote on: election of seven directors, ratification of Baker Tilly US, LLP as auditor, advisory vote on executive compensation, and advisory vote on frequency of future say-on-pay votes
- Proxy statement and annual report for FY ended December 31, 2025 are available via internet notice mailed on or about October 8, 2026
- Filing is additional definitive proxy soliciting material (DEFA14A), no new proposals or changes from the previously filed DEF 14A
Financial Impact
No financial figures disclosed in this filing
Risk Factors
- No material risks identified from this routine proxy notice
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001129928-26-000067 |
| Document: 0001129928-26-000067-index-headers.html | 0001129928-26-000067 |
| Document: 0001129928-26-000067-index.html | 0001129928-26-000067 |
| Document: 0001129928-26-000067.txt | 0001129928-26-000067 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 2d ago | 8-K | $0.4623 | awaiting T+20 | awaiting T+20 | $0.4342 (−6.08%) |
Oct 27, 2026 2d ago | Press Release | $0.4623 | awaiting T+20 | awaiting T+20 | $0.4342 (−6.08%) |
Oct 20, 2026 9d ago | 8-K | $0.4986 | awaiting T+20 | awaiting T+20 | $0.4342 (−12.92%) |
Oct 20, 2026 9d ago | Press Release | $0.4986 | awaiting T+20 | awaiting T+20 | $0.4342 (−12.92%) |
Oct 14, 2026 15d ago | 8-K | $0.5382 | awaiting T+20 | awaiting T+20 | $0.4342 (−19.32%) |
Oct 13, 2026 16d ago | 8-K | $0.4900 | awaiting T+20 | awaiting T+20 | $0.4342 (−11.39%) |
Oct 6, 2026 22d ago | DEFA14A | $0.6000 | awaiting T+20 | awaiting T+20 | $0.4342 (−27.63%) |
Oct 6, 2026 22d ago | DEF 14A | $0.6000 | awaiting T+20 | awaiting T+20 | $0.4342 (−27.63%) |
Sep 29, 2026 4w ago | 8-K | $0.6745 $0.4623 | ▼ −31.46% | ▼ −32.17% | $0.4342 (−35.63%) |
Sep 28, 2026 4w ago | 8-K | $0.6630 $0.4732 | ▼ −28.63% | ▼ −28.60% | $0.4342 (−34.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers